The CEO of the giant pharmaceutical company "AstraZeneca" said that the candidate vaccine for the Coronavirus may be ready for use at the end of December 1, pending regulatory approval.
Suriot indicated that many experts believe that revaccination will be required. "If we must do this annually, we can make money from 2022," he added.
Source: Al-Ahram Gate